These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 20302635)

  • 1. Microrna profiling analysis of differences between the melanoma of young adults and older adults.
    Jukic DM; Rao UN; Kelly L; Skaf JS; Drogowski LM; Kirkwood JM; Panelli MC
    J Transl Med; 2010 Mar; 8():27. PubMed ID: 20302635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global microRNA profiling of metastatic conjunctival melanoma.
    Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S
    Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Markers in Melanoma Progression: A Study on the Expression of miRNA Gene Subtypes in Tumoral vs. Benign Nevi.
    Prodan M; Costescu S; Elagez A; Laitin SMD; Bloanca V; Crainiceanu Z; Seclaman E; Toma AO; Fericean RM; Puenea G; Cozma GV
    Curr Oncol; 2024 May; 31(5):2881-2894. PubMed ID: 38785501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.
    Venkatesan N; Kanwar J; Deepa PR; Khetan V; Crowley TM; Raguraman R; Sugneswari G; Rishi P; Natarajan V; Biswas J; Krishnakumar S
    PLoS One; 2016; 11(1):e0146128. PubMed ID: 26812476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling.
    Glud M; Klausen M; Gniadecki R; Rossing M; Hastrup N; Nielsen FC; Drzewiecki KT
    J Invest Dermatol; 2009 May; 129(5):1219-24. PubMed ID: 19005486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
    Latchana N; Del Campo SE; Grignol VP; Clark JR; Albert SP; Zhang J; Wei L; Aldrink JH; Nicol KK; Ranalli MA; Peters SB; Gru A; Trihka P; Payne PR; Howard JH; Carson WE
    Ann Surg Oncol; 2017 Feb; 24(2):347-354. PubMed ID: 27469124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
    Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
    Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in microRNA expression between melanoma and healthy adjacent skin.
    Aksenenko M; Palkina N; Komina A; Tashireva L; Ruksha T
    BMC Dermatol; 2019 Jan; 19(1):1. PubMed ID: 30611259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors.
    Latchana N; Regan K; Howard JH; Aldrink JH; Ranalli MA; Peters SB; Zhang X; Gru A; Payne PRO; Suarez-Kelly LP; Carson WE
    J Surg Res; 2016 Oct; 205(2):350-358. PubMed ID: 27664883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of microRNA-21 and microRNA-125b in melanoma tissue.
    Wandler A; Riber-Hansen R; Hager H; Hamilton-Dutoit SJ; Schmidt H; Nielsen BS; Stougaard M; Steiniche T
    Melanoma Res; 2017 Oct; 27(5):417-428. PubMed ID: 28614272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells.
    Komina A; Palkina N; Aksenenko M; Tsyrenzhapova S; Ruksha T
    PLoS One; 2016; 11(12):e0168229. PubMed ID: 28005927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
    Yang Y; Mei Q
    Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
    Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
    RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers.
    Nurul-Syakima AM; Yoke-Kqueen C; Sabariah AR; Shiran MS; Singh A; Learn-Han L
    Int J Mol Med; 2011 Sep; 28(3):327-36. PubMed ID: 21637912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
    Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
    Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA signatures in hereditary breast cancer.
    Murria Estal R; Palanca Suela S; de Juan Jiménez I; Egoavil Rojas C; García-Casado Z; Juan Fita MJ; Sánchez Heras AB; Segura Huerta A; Chirivella González I; Sánchez-Izquierdo D; Llop García M; Barragán González E; Bolufer Gilabert P
    Breast Cancer Res Treat; 2013 Nov; 142(1):19-30. PubMed ID: 24129975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue microRNA expression profiling in hepatic and pulmonary metastatic melanoma.
    DiVincenzo MJ; Latchana N; Abrams Z; Moufawad M; Regan-Fendt K; Courtney NB; Howard JH; Gru AA; Zhang X; Fadda P; Carson WE
    Melanoma Res; 2020 Oct; 30(5):455-464. PubMed ID: 32804708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-10b is a prognostic biomarker for melanoma.
    Saldanha G; Elshaw S; Sachs P; Alharbi H; Shah P; Jothi A; Pringle JH
    Mod Pathol; 2016 Feb; 29(2):112-21. PubMed ID: 26743475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.